Artemis Medicare Services Limited

Healthcare · Healthcare Services

NSE: ARTEMISMED BSE: 542919
₹345.55
Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Healthcare Services

The largest companies in the same industry by market cap. This company ranks #22 of 62. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Apollo Hospitals Enterprise Limited 117,407 74.7 20.1% 9.7% — 73 0 27
Max Healthcare Institute Limited 90,492 126.0 13.4% -16.5% 0.22% 77 0 26
Fortis Healthcare Limited 58,132 257.5 10.5% -22.2% 0.13% 49 26 6
Global Health Limited 36,701 76.2 13.9% 4.6% 0.04% 74 0 30
Narayana Hrudayalaya Ltd. 36,609 64.4 17.8% 3.5% 0.25% 66 0 29
Aster DM Quality Care Limited 36,121 207.5 8.8% 10.5% 0.43% 53 0 26
Dr. Lal Path Labs Ltd. 33,310 38.7 20.1% -37.3% 0.98% 82 0 88
Krishna Institute of Medical Sciences Limited 31,349 111.2 9.5% 8.5% — 47 0 29
Artemis Medicare Services Limited (this stock) 5,470 48.3 11.0% 47.2% — 67 24 85

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value
₹5,663 Cr
EV / EBITDA
25.2x
EV / Sales
5.18x
Market cap / Sales
5.01x
Earnings yield
2.07%

Quarterly Financials

↑ Positive
Quarterly Revenue

Jun 2026 quarterly revenue is Rs 287 Cr, up 11.9% YoY.

↑ Positive
Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 31 Cr, up 45.0% YoY.

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 282 42 31 ₹1.9600
March 31, 2026 274 39 30 ₹1.8700
Dec. 31, 2025 267 30 23 ₹1.4200
Sept. 30, 2025 270 40 30 ₹1.9000
June 30, 2025 250 30 21 ₹1.3600
March 31, 2025 235 29 23 ₹1.4800
Dec. 31, 2024 227 27 21 ₹1.3300
Sept. 30, 2024 235 31 23 ₹1.4400
June 30, 2024 217 22 17 ₹1.1600
March 31, 2024 217 19 14 ₹1.0200
Dec. 31, 2023 210 16 12 ₹0.8500
Sept. 30, 2023 217 19 14 ₹1.0100
June 30, 2023 201 13 10 ₹0.7300

Quarterly income statement (standalone, ₹ Cr)

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
Total income (before exceptional items)287281275278257247236242221219212219202
Operating revenue282274267270250235227235217217210217201
Other income58787129742221
Operating expenses227223223220209199190193181181179184174
Operating profit55504450413637423636323327
Operating profit margin19.7%18.4%16.4%18.6%16.4%15.1%16.2%17.8%16.4%16.7%15.1%15.4%13.5%
Depreciation121212111111111110101099
Interest6677788888876
Exceptional items, gain / (loss)——-3——————————
Profit before tax42393040302927312219161913
Tax1110710966956553
Net profit3130233021—21231714121410
EPS1.961.871.421.901.361.481.331.441.161.020.851.010.73
Net profit (TTM)113103————74655649464439
EPS (TTM)7.156.556.166.075.615.414.954.474.043.613.373.252.90

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year endedRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)
March 31, 2026 1,060 139 103
March 31, 2025 913 109 83
March 31, 2024 845 68 49
March 31, 2023 714 53 40

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 25Mar 24Mar 23Mar 22Mar 21
Total income (before exceptional items) — 21.9% 1,090†946†853†—549†406†
Operating revenue 14.1% 21.4% 1,060913845714545†402†
Other income — — 30†33†7†—4†4†
Operating expenses — — 875†763†717†—478†367†
Operating profit — 39.5% 185†150†128†—67†35†
Operating profit margin — — 17.5%†16.4%†15.2%†—12.3%†8.7%†
Depreciation — — 46†43†38†—21†21†
Interest — — 27†30†30†—11†12†
Exceptional items, gain / (loss) — — -3†0†0†—0†3†
Profit before tax 37.9% 73.2% 139109685339†9†
Tax — — 35†26†19†—6†2†
Net profit 37.6% 70.9% 10383494033†7†
EPS — 4.1% 6.55†5.41†3.61†—5.29†5.36†

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 25Mar 24Mar 23Mar 22Mar 21
Operating margin17.5%†16.4%†15.2%†—12.3%†8.7%†
EBIT margin15.6%†15.3%†11.6%†—9.2%†5.3%†
PBT margin13.1%12.0%8.0%7.4%7.1%†2.2%†
Net margin9.8%9.1%5.8%5.6%6.0%†1.8%†
Interest coverage6.15x†4.58x†3.30x†—4.48x†1.73x†
Dividend payout——————
Earnings retention——————
Current ratio1.73x2.54x————
Quick ratio1.67x2.50x————
Debt to equity0.24x0.28x————
Return on equity11.0%9.9%————
Return on assets7.3%6.2%————
Return on capital employed13.6%†12.3%†————
Asset turnover0.74x0.68x————

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 129 -96 -41 105 24
March 31, 2025 139 -388 277 93 46
March 31, 2024 108 -89 -27 72 36
March 31, 2023 129 -153 30 136 -7
March 31, 2022 61 -106 44 107 -46

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 1,424 939 923 36 190 358 207 33 708 13
March 31, 2025 1,343 842 828 32 204 527 207 41 640 9
March 31, 2024 — — — — — — — — — —
March 31, 2023 — — — — — — — — — —
March 31, 2022 — — — — — — — — — —

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.